Holen Sie sich die Stockscreener-App
1.64
7.87%
-0.14
Vorhandelsmarkt:
1.74
0.10
+6.10%
Pluri Inc Aktie (PLUR) Neueste Nachrichten
Pluri Inc (PLUR) Balance Sheet - TradingKey
PLUR|Pluri Inc|Price:1.780|Chg%:-0.040 - TradingKey
Pluri Inc (PLUR) Cash Flow - TradingKey
Pluri Inc (PLUR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Pluri Inc (PLUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Enterprise value to revenue forward of Pluri Inc. – NASDAQ:PLUR - TradingView
Enterprise value to revenue forward of Pluri Inc. – FWB:4DX - TradingView
Plurilock Security Inc.'S Aurora Subsidiary Announces Selection as SEWP VI Awardee Enabling U.S. Federal Agencies to Procure It and Cybersecurity Solutions - marketscreener.com
Price to book forward of Pluri Inc. – LS:A408KW - TradingView
Pluri in ongoing talks to extend EIB financing - The Globe and Mail
Pluri Inc. Files 8-K: Company Updates, NASDAQ Listing, and EIB Loan Discussions – July 2026 - Minichart
Pluri chairman raises stake above 30%; shares up - MSN
Pluri's Chairman Increases Investment and Ownership Stake (PLUR) - GuruFocus
Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30% - marketscreener.com
Pluri Chairman Builds 30%-Plus Position With $17M Investment - Stock Titan
Pluri Receives Nasdaq Non-Compliance Notice, Faces Delisting Risk - TipRanks
Pluri Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Pluri (PLUR) director Doron Shorrer files Form 3 listing share holdings - Stock Titan
PLURPluri Inc Latest SEC Filings - Finviz
Pluri Inc. Q2 2026 Earnings: EPS Misses Estimates as Stock Holds SteadyDividend Increase Stocks - dars.gov.et
Pluri Inc. Q2 2026 Earnings: Wider-than-Expected Loss Drives Stock DeclineSlow Growth Warning - dars.gov.et
Pluri (NASDAQ: PLUR) director logs RSU grant as 625,000 warrants expire - Stock Titan
Synthetic Stem Cell Market to Witness Massive Growth by 2033 | - openPR.com
Form 13D/A Pluri Inc. For: 1 July By Investing.com - Investing.com UK
Price to sales forward of Pluri Inc. – NASDAQ:PLUR - TradingView
Enterprise value to EBITDA forward of Pluri Inc. – NASDAQ:PLUR - TradingView
Price to earnings forward of Pluri Inc. – NASDAQ:PLUR - TradingView
Price to earnings forward of Pluri Inc. – TASE:PLUR - TradingView
Pluri Inc. Actuals & Estimates (NASDAQ:PLUR) - TradingView
Pluri Inc. Actuals & Estimates (FWB:4DX) - TradingView
Pluri Inc. Actuals & Estimates (TASE:PLUR) - TradingView
Pluri Inc (PLUR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Brevel and Coffeesai Trial Illuminated Fermentation to Push Cell-Based Coffee Toward Commercial Scale - Cultivated X
RGNT PE Ratio & Valuation, Is RGNT Overvalued - Intellectia AI
Pluri Secures Insider Advance Subscription to Boost Liquidity - TipRanks
Pluri (NASDAQ: PLUR) gets $1,250,000 insider advance and appoints new director - Stock Titan
PLUR Q1 2026 Earnings: EPS Miss Drives Double-Digit Stock DeclineManagement Tone Analysis - dars.gov.et
Pluri Inc (PLUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Pluri Inc (PLUR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Pluri Inc (PLUR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Pluri Inc (PLUR) Institutional Confidence - TradingKey
Pluri Inc (PLUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BSX Q1 2026 Earnings: Slight EPS Beat as Core Segments Show ResilienceEPS Growth Report - newsline.com
Pluri Inc. Q1 2026 Earnings: EPS Misses Estimates Amid Ongoing Operational InvestmentsEPS Growth Report - dars.gov.et
Pluri Inc. (PLUR) Edges Higher as Stock Nears Key Resistance LevelMarket Leader Picks - newsline.com
Elon Musk Reaches Trillion-Dollar Milestone as SpaceX Nasdaq Debut Propels Net WorthBook Value Growth - newsline.com
Pluri Inc. Q1 2026 Earnings: EPS Misses as Pre-Revenue Biotech Continues Pipeline DevelopmentReturn On Assets - newsline.com
SBSI Q1 2026 Earnings: EPS Surpasses Estimates, No Revenue Data ProvidedAnnual Earnings Summary - newsline.com
PLUR Q1 2026 Earnings: EPS Misses Estimates as Company Reports No RevenueRevenue Surprise History - dars.gov.et
PLUR Q1 2026 Earnings: EPS Misses Estimates as Revenue Remains AbsentHealthcare Earnings Report - newsline.com
UnitedHealth Raises Dividend 5% Amid Rising Healthcare CostsEarnings Decline Risk - newsline.com
Made Scientific, Pluristyx launch development and manufacturing partnership - ROI-NJ
Made Scientific and Pluristyx Launch Integrated iPSC Development & Manufacturing Partnership to Advance Next-Generation iPSC-derived Cell Therapies - The Malaysian Reserve
Pluri subsidiary completes U.S. cosmetic listing for two products By Investing.com - Investing.com Nigeria
Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing - The Manila Times
Pluri subsidiary completes U.S. cosmetic listing for two products - Investing.com
Two new skin treatments target $90B U.S. aesthetics market - Stock Titan
Pluri's Leap from Lab to Luxury: A High-Stakes Bet on Regenerative Beauty - BriefGlance
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):